News

Viewing Page 1 of 1 | Showing Results 1 of 1

Breakthrough lung cancer drug helps clinical trial patient

March 06, 2015

A breakthrough drug for treating the most common type of lung cancer was just approved by the Food and Drug Administration ahead of schedule following two successful clinical trials, including one that involved patients at Providence Cancer Center in Portland.

Viewing Page 1 of 1 | Showing Results 1 of 1